TY  - GEN
AU  - Svensson,Tobias
AU  - Chowdhury,Onima
AU  - Garelius,Hege
AU  - Lorenz,Fryderyk
AU  - Saft,Leonie
AU  - Jacobsen,Sten-Eirik
AU  - Hellström-Lindberg,Eva
AU  - Cherif,Honar
TI  - A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine
SN  - 1600-0609
PY  - 2015///0611
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Azacitidine
KW  - Benzoates
KW  - Blood Platelets
KW  - drug effects
KW  - Cell Cycle
KW  - Drug Synergism
KW  - Drug Therapy, Combination
KW  - Female
KW  - Hematopoietic Stem Cells
KW  - Humans
KW  - Hydrazines
KW  - Ischemic Attack, Transient
KW  - etiology
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - complications
KW  - Pilot Projects
KW  - Platelet Count
KW  - Pyrazoles
KW  - Receptors, Thrombopoietin
KW  - agonists
KW  - Remission Induction
KW  - Thrombocytopenia
KW  - Treatment Outcome
KW  - Venous Thrombosis
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/ejh.12383
ER  -